re: 1164.HK - Vital Biotech - HK listed - HK$0.64
FINANCIAL DATA
· Profit and Loss Statement
Year 2002 2001 2000 1999
year endedcurrency typevalue 31-DecHKD000 31-DecHKD000 31-DecHKD000 31-DecHKD000
Turnover 167,969 122,825 64,128 22,875
Operating profit 54,210 42,498 17,190 3,379
Finance costs ( 4,903) ( 3,399) ( 1,893) ( 2,233)
Profit before tax 49,307 39,099 15,297 1,146
Net profit 48,319 39,099 15,282 1,146
Minority Interest ( 7,727) ( 914) ( 743) ( 545)
Profit Attrib to Shareholder 40,592 38,125 14,539 601
· Balance Sheet
Year 2002 2001 2000
year endedcurrency typevalue 31-DecHKD000 31-DecHKD000 31-DecHKD000
Fixed Assets 101,775 36,548 14,174
Investments 3,900 - -
Current Assets 167,955 69,866 54,643
Defered Items/Other Assets/Intangibles 8,144 8,712 8,963
Current Liabilities 84,155 46,089 60,095
Long-term Liabilities/Deferred Liabilities 21,060 15,043 1,935
Share Capital 12,273 182 182
Reserves 164,286 53,812 15,568
Shareholder's Funds* 176,559 53,994 15,750
NAV ($) 0.14 0.06 0.02
Cash Flow Statement
Year 2002 2001
year endedcurrency typevalue 31-DecHKD000 31-DecHKD000
Net Cash at Beginning 4,663 4,860
inflow (outflow) from operating activities 19,707 28,208
Inflow (Outflow) from financing 107,102 4,848
inflow (outflow) from investing activities ( 73,496) ( 33,253)
Net Cash (Outflow) 53,313 ( 197)
Net Cash at End 57,976 4,663
Cash Flow Statement
HKD thousand Dec-2002 Dec-2001 Dec-2000
Net cash inflow/(outflow) from operating activities 19,707 28,208 12,004 - -
Net cash inflow/(outflow) from investing activities (73,496) (33,253) (9,869) - -
Net cash inflow/(outflow) from financing activities 107,102 4,848 1,813 - -
Increase/(decrease) in cash and cash equivalents 53,313 (197) 3,948 - -
Cash and cash equivalents at the beginning of fiscal year 4,663 4,860 912 - -
Cash and cash equivalents at the end of fiscal year 57,976 4,663 4,860 |
